Rhodococcus IgG Equine Plasma

Rhodococcus IgG 950ml
500ml - 500ml
1000ml - 1000ml
SKU : 4214500
Call to order - xxx-xxx-xxxx
by Lake Immunogenics Inc

Please call to place order, as additional charges will apply

A prophylactic treatment for the prevention or reduction in severity of Rhodococcus equi foal pneumonia. Clinical Results: 58% reduction in the incidence of R. equi pneumonia when all foals were given two doses of Rhodococcus Equi Antibody in the first month of life.

For more information, see: Lake Immunogenics, Inc. or their product sheet.
Customer Reviews
# of Ratings: 0


Lake Immunogenics

Rhodococcus Equi Antibody

Equine Origin

For Veterinary Use Only

300 ml, 500 ml, 1000 ml

For intravenous use in the horse as an aid in the control of disease caused by Rhodococcus equi infection in the neonate. The average 100 lb. foal should receive one 1000 ml unit intravenously within the first 5 days of life. A second 1000 ml dose should be administered preceding the onset of infection in your particular endemic area. The primary incidence of this disease occurs between 6-12 weeks of age, but in endemic areas if exposure and environmental conditions favoring exposure are present, an additional dose may be necessary for foals up to 16 weeks of age.

Each single dose bag contains plasma as a source of Rhodococcus equi antibodies with sodium citrate as an anticoagulant derived from healthy horses with Aa and Ca r.b.c. antigens and no r.b.c. antibodies. All donor horses are negative for EIA, EVA, Dourine, Brucellosis, Piroplasmosis and Glanders. There is no preservative added. KEEP FROZEN UNTIL USE. Thaw quickly in warm water not exceeding 110F. DO NOT MICROWAVE.

Administer as soon as possible after thawing by filtered intravenous infusion and discard any unused portion. Although rapid administration is possible, extreme caution and close monitoring is essential in this situation. In case of a reaction, marked most often by tenesmus and hyperventilation, slow the speed of administration. If this does not abate the signs, stop administration until signs abate, and continue at a slower rate. If signs persist suspend administration and treat with histamine blockers and anti-inflammatory agents. Administration may be attempted again after treatment to relieve the adverse response has been successful.

CAUTION: This product has not been processed by heating or treating with ionizing radiation and may be capable of spreading disease. Anaphylaxis may occur with the use of this product.

US Vet Lic. No. 318


NAC No.: 1119003.6